Anti-inflammatory drugs with more penetration into the central nervous system may contribute to the treatment of trigeminal neuralgia

Pain. 2019 Dec;160(12):2898. doi: 10.1097/j.pain.0000000000001698.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents
  • Biomarkers
  • Humans
  • Inflammation
  • Microvascular Decompression Surgery*
  • Trigeminal Neuralgia*

Substances

  • Anti-Inflammatory Agents
  • Biomarkers